Bio Green Med Solution (BGMS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
18 Jun, 2026Opening remarks and agenda
Meeting called to order at 12:30 P.M. Eastern Time, with board members, senior management, and legal counsel present virtually.
Agenda and rules of procedure were made available to attendees via the virtual portal.
Board and executive committee updates
Two individuals, Dr. Satis Waran Nair Krishnan and Inigo Angel Laurduraj, were nominated for re-election as Class I directors for a three-year term expiring at the 2029 annual meeting.
Shareholder proposals
Three proposals were presented: election of Class I directors, ratification of independent auditors, and advisory approval of executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Bio Green Med Solution
- Q1 2026 fire safety revenue hit $0.8M, but future viability hinges on new funding.BGMS
Q1 202615 May 2026 - Stockholders will vote virtually on director elections, auditor ratification, and executive pay approval.BGMSProxy filing1 May 2026
- Shareholders will virtually vote on directors, auditor ratification, and executive pay, all recommended for approval.BGMSProxy filing27 Apr 2026
- Net loss narrowed to $3.0 million in 2025 as fire safety revenue reached $0.7 million.BGMSQ4 202530 Mar 2026
- Lower Q2 loss and R&D spend, but cash runway and compliance risks persist.BGMSQ2 20241 Feb 2026
- FADRA demonstrates durable responses in biomarker-driven cancer trials; PLOGO reformulation underway.BGMSH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Stockholders will vote on key proposals that could shift control and restructure the company's capital.BGMSProxy Filing2 Dec 2025
- Shareholders to vote on equity issuances, reverse split, and governance changes to secure funding.BGMSProxy Filing2 Dec 2025
- Shareholders to vote on equity issuances, reverse split, and governance changes to ensure compliance.BGMSProxy Filing2 Dec 2025